Quantifying SARS-CoV-2 Infection Risk Within the Google/Apple Exposure Notification Framework to Inform Quarantine Recommendations.
Bluetooth technology
COVID-19
digital contact tracing
proximity sensing
Journal
Risk analysis : an official publication of the Society for Risk Analysis
ISSN: 1539-6924
Titre abrégé: Risk Anal
Pays: United States
ID NLM: 8109978
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
31
01
2021
received:
25
09
2020
accepted:
24
05
2021
pubmed:
23
6
2021
medline:
1
4
2022
entrez:
22
6
2021
Statut:
ppublish
Résumé
Most early Bluetooth-based exposure notification apps use three binary classifications to recommend quarantine following SARS-CoV-2 exposure: a window of infectiousness in the transmitter, ≥15 minutes duration, and Bluetooth attenuation below a threshold. However, Bluetooth attenuation is not a reliable measure of distance, and infection risk is not a binary function of distance, nor duration, nor timing. We model uncertainty in the shape and orientation of an exhaled virus-containing plume and in inhalation parameters, and measure uncertainty in distance as a function of Bluetooth attenuation. We calculate expected dose by combining this with estimated infectiousness based on timing relative to symptom onset. We calibrate an exponential dose-response curve based on infection probabilities of household contacts. The probability of current or future infectiousness, conditioned on how long postexposure an exposed individual has been symptom-free, decreases during quarantine, with shape determined by incubation periods, proportion of asymptomatic cases, and asymptomatic shedding durations. It can be adjusted for negative test results using Bayes' theorem. We capture a 10-fold range of risk using six infectiousness values, 11-fold range using three Bluetooth attenuation bins, ∼sixfold range from exposure duration given the 30 minute duration cap imposed by the Google/Apple v1.1, and ∼11-fold between the beginning and end of 14 day quarantine. Public health authorities can either set a threshold on initial infection risk to determine 14-day quarantine onset, or on the conditional probability of current and future infectiousness conditions to determine both quarantine and duration.
Identifiants
pubmed: 34155669
doi: 10.1111/risa.13768
pmc: PMC8447042
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
162-176Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES006694
Pays : United States
Informations de copyright
© 2021 The Authors. Risk Analysis published by Wiley Periodicals LLC on behalf of Society for Risk Analysis.
Références
Swiss Med Wkly. 2020 Aug 05;150:w20336
pubmed: 32757177
Nat Hum Behav. 2020 Sep;4(9):964-971
pubmed: 32759985
Front Med (Lausanne). 2021 Mar 15;8:595773
pubmed: 33791320
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Nature. 2021 Jun;594(7863):408-412
pubmed: 33979832
Science. 2020 May 8;368(6491):
pubmed: 32234805
Innovation (Camb). 2020 Nov 25;1(3):100061
pubmed: 33169119
Public Health. 2020 May;182:163-169
pubmed: 32334182
Front Neurorobot. 2020 Jan 21;13:113
pubmed: 32038220
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340347
JAMA Netw Open. 2020 May 1;3(5):e2010182
pubmed: 32459353
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
J Aerosol Sci. 2020 Sep;147:105585
pubmed: 32427227
Science. 2020 Jun 26;368(6498):1422-1424
pubmed: 32461212
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22020-5
pubmed: 21149721
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Swiss Med Wkly. 2020 Dec 16;150:w20457
pubmed: 33327003
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Clin Infect Dis. 2020 Dec 17;71(10):2679-2687
pubmed: 32497212
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
BMJ. 2020 Aug 25;370:m3223
pubmed: 32843355
Sci China Life Sci. 2020 May;63(5):706-711
pubmed: 32146694
J R Soc Interface. 2011 Aug 7;8(61):1176-84
pubmed: 21300628
Int J Infect Dis. 2020 Sep;98:252-260
pubmed: 32619760
Lancet Digit Health. 2020 Dec;2(12):e658-e666
pubmed: 33078140
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
Int J Environ Res Public Health. 2020 Feb 24;17(4):
pubmed: 32102305
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
Epidemiol Infect. 2007 Aug;135(6):914-21
pubmed: 17217552
Elife. 2017 Dec 21;6:
pubmed: 29266000
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
BMC Infect Dis. 2011 Sep 30;11:257
pubmed: 21958428
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Health Care Manag Sci. 2007 Dec;10(4):341-55
pubmed: 18074967
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Emerg Infect Dis. 2020 Aug;26(8):1917-1920
pubmed: 32412896
J R Soc Interface. 2021 Sep;18(182):20210459
pubmed: 34493093
Science. 2021 Apr 16;372(6539):
pubmed: 33688063
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Lancet Respir Med. 2020 Sep;8(9):914-924
pubmed: 32717211
Epidemiol Infect. 2009 Jan;137(1):30-7
pubmed: 18387216